Literature DB >> 35994179

Cognitive deficits in primary hyperparathyroidism - what we know and what we do not know: A narrative review.

Manju Chandran1,2, Lydia Tan Li Yeh3, Mechteld C de Jong3, John P Bilezikian4, Rajeev Parameswaran3,5.   

Abstract

Classic symptoms of primary hyperparathyroidism (PHPT) are seen in approximately 20% of patients. While features such as kidney stones and skeletal disease are often highlighted as directly related to the disease, others can be even more prevalent. For example, cognitive dysfunction and reduced quality of life are common complaints in many patients, even among those who are classified as being asymptomatic. The pathophysiology of PHPT involves the impact of excess parathyroid hormone (PTH) on calcium metabolism. Referencing putative neurocognitive issues, many animal studies have illustrated the potential roles of PTH and PTH receptors in the brain. Functional imaging and pre-and post-parathyroidectomy studies have suggested a link between the neuronal impact of elevated PTH levels on specific functional aspects of the central nervous system, such as cognition. Confounding a direct role for PTH are hypercalcemia and vitamin D deficiency, both of which could conceivably alter CNS function in PHPT. The lack of strong evidence that parathyroidectomy improves cognition in patients with PHPT raises the question as to whether parathyroid surgery should be recommended on this basis alone. This narrative review summarizes the available literature on neurocognitive function in PHPT.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cognition; Cognitive symptoms; Neurologic, Psychiatric; Parathyroidectomy; Primary hyperparathyroidism

Mesh:

Substances:

Year:  2022        PMID: 35994179     DOI: 10.1007/s11154-022-09750-9

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   9.306


  64 in total

Review 1.  Non classical complications of primary hyperparathyroidism.

Authors:  I Chiodini; E Cairoli; S Palmieri; J Pepe; M D Walker
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-06-18       Impact factor: 4.690

Review 2.  Primary Hyperparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

Review 3.  Consequences of age-related cognitive declines.

Authors:  Timothy Salthouse
Journal:  Annu Rev Psychol       Date:  2011-07-05       Impact factor: 24.137

Review 4.  Primary hyperparathyroidism, cognition, and health-related quality of life.

Authors:  Laura H Coker; Kashemi Rorie; Larry Cantley; Kimberly Kirkland; David Stump; Nicole Burbank; Terry Tembreull; Jeff Williamson; Nancy Perrier
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

5.  Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago.

Authors:  Ewa Lundgren; Emil G Hagström; Jonas Lundin; Kajsa Winnerbäck; Johanna Roos; Sverker Ljunghall; Jonas Rastad
Journal:  World J Surg       Date:  2002-06-06       Impact factor: 3.352

Review 6.  International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors--family B G protein-coupled receptors.

Authors:  Thomas J Gardella; Jean-Pierre Vilardaga
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

7.  Anatomical profiling of G protein-coupled receptor expression.

Authors:  Jean B Regard; Isaac T Sato; Shaun R Coughlin
Journal:  Cell       Date:  2008-10-31       Impact factor: 41.582

Review 8.  Nonclassical symptoms of primary hyperparathyroidism and their response to parathyroidectomy.

Authors:  Gillian Alex; Lilah Morris; Janice Pasieka; Nancy Perrier
Journal:  Am Surg       Date:  2013-04       Impact factor: 0.688

Review 9.  Classical complications of primary hyperparathyroidism.

Authors:  Salvatore Minisola; Laura Gianotti; Sanjay Bhadada; Shonni J Silverberg
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-09-12       Impact factor: 4.690

10.  The Impact of Age on Cognition.

Authors:  Daniel L Murman
Journal:  Semin Hear       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.